Vitaline CoQ10

300 mg Vitaline CoQ10, 60 wafers/bottle for
400 mg Vitaline CoQ10, 90 wafers/bottle for

FREE shipping in the USA!

"These positive results are a sign of hope for those suffering from Parkinson’s Disease," said M. Flint Beal, M.D, professor and chairman, Department of Neurology Cornell University Medical College. "Research on CoQ10 must continue so that we may verify and move forward our current understanding of this powerful nutrient, and its role within the human brain."

Parkinson’s Disease is a degenerative neurological disorder that is characterized by resting tremors, slowness of movement and muscular rigidity. Parkinson’s Disease affects approximately one percent of the population over 65 years of age.

No other treatment has been shown to slow the progression of this deadly disease!

"Clearly the data of the Parkinson Study Group in this article are intriguing and provocative therapeutic findings and offer considerable potential hope for future allied therapies," said Roger Rosenberg, editor of Archives of Neurology, in an editorial.

The study was conducted by the University of California San Diego in association with the Parkinson’s Disease Study Group, the Clinical Trials Coordination Center and the Department of Biostatistics at the University of Rochester at 10 research sites across the country.

Vitaline CoQ10 has been the subject of more than 20 research studies, review articles, and abstract presentations. Vitaline CoQ10 is especially attractive because it is safe in high dosages and has been proven to penetrate the cell. It is the ONLY CoQ10 of the hundreds on the market to meet both these criteria.

Vitaline CoQ10 has a unique and proprietary formula, delivery mechanism and manufacturing process, for which it has developed multiple patents pending. Other CoQ10-containing products have not been proven safe, tolerable or effective. Many readily available CoQ10-containing products contain ingredients which are harmful at the high doses used in the clinical research.

Recently, researchers from Harvard Medical School found Vitaline CoQ10 successfully crosses the blood-brain barrier to enter and increase the amount of CoQ10 in the cell mitochondria. Vitaline CoQ10 is unique for this reason, as no other CoQ10 has been proven to do this.

Vitaline CoQ10 has a unique and proprietary formula, delivery mechanism and manufacturing process, for which it has developed multiple patents pending. Other CoQ10-containing products have not been proven safe, tolerable or effective. Many readily available CoQ10-containing products contain ingredients which are harmful at the high doses used in the clinical research.

We carry the 300 mg CoQ10 used in the above mentioned Parkison's study that has 300 IU of vitamin E. We also have the 300 mg CoQ10 wafers with NO vitamin E as well as the 400 mg CoQ10 wafers with 200 IU We offer FREE shipping on these products for customers in the US.

Purchase Vitaline®'s Coenzyme Q10 via our SECURE Order Form!

Return to Nature Doc's On-Line Catalog.